Allergy Clinical Trial
Background:
Respiratory allergic reaction causes great suffering to millions of people worldwide. One of
the most known allergen- is the pollen from vegetation, ragweed. Genus Ambrosia Ambrosia
belonged to the complex ragweed flowers are pollinated by the wind and the plant's male
flowers produce large quantities of small grains of pollen and airborne over long distances
and those causes allergic reactions. The plant blooms between June and October, creating a
second wave after wave of allergy caused by spring blossoms.
This plant originated in North America has invaded many areas in Europe and in recent years,
taking over large areas in Israel, Hula Valley and northern Acre Emek Hefer for a pen and
layers to the south. After ragweed plants are based in particular they spread quickly and
invade agricultural fields and significantly reduce the crop.
High allergenic ragweed is a health hazard to humans. Ragweed plant investigated many
aspects of North America and Europe in recent decades and extensive literature on ambrosia,
but this is the first time ragweed study focuses on Israel.
Working hypothesis and aims:
Goal of this study is to identify the existence and nature of the sensitivity distribution
of ragweed in Israel.
Importance of research:
A. Ragweed allergen testing and comparing the effect of exposure to plants on the
sensitivity of the allergic Israeli patients
B. The inclusion of ragweed allergen in the diagnostic and therapeutic panel
| Status | Not yet recruiting |
| Enrollment | 200 |
| Est. completion date | December 2012 |
| Est. primary completion date | December 2012 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - respiratory allergic patients Exclusion Criteria: - non respiratory allergic patients |
Observational Model: Cohort
| Country | Name | City | State |
|---|---|---|---|
| n/a | |||
| Lead Sponsor | Collaborator |
|---|---|
| Rambam Health Care Campus |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT02032056 -
Effect of Probiotics in Reducing Infections and Allergies in Young Children During the Complementary Feeding Period
|
N/A | |
| Completed |
NCT01842711 -
Cumulative Irritation Patch Test
|
N/A | |
| Completed |
NCT01633840 -
New Validated Recipes for Double-blind Placebo-controlled Low Dose Food Challenges
|
N/A | |
| Completed |
NCT00997971 -
Growth, Tolerance in Healthy Infants Fed a Partially Hydrolyzed Rice Protein
|
Phase 3 | |
| Completed |
NCT00554983 -
Efficacy and Safety From a Recombinant Folding Variant of Bet v 1
|
Phase 3 | |
| Completed |
NCT00331929 -
Respiratory Health Study of Children in Kiryat Tivon
|
N/A | |
| Completed |
NCT00220753 -
Air Cleaners for Children and Adolescents With Asthma and Dog Allergy
|
N/A | |
| Completed |
NCT00232518 -
Randomised Controlled Clinical Trials of the Effect of Therapeutic Hookworm Infection in Allergic Rhinoconjunctivitis
|
N/A | |
| Completed |
NCT04046731 -
Neuromuscular Blocking Agents Utilized During Perioperative Hypersensitivity Evaluation
|
N/A | |
| Completed |
NCT04126096 -
Negative Predictive Value and NIC of Beta-Lactam Antibiotics.
|
N/A | |
| Completed |
NCT04004351 -
Treatment Modalities in Children and Adolescents Suffering From HDM-induced Allergic Rhinitis and/or Asthma
|
||
| Not yet recruiting |
NCT05997784 -
Study of Indoor Air Pollutants and Their Impact in Childhood Health and Wellbeing
|
||
| Completed |
NCT04418999 -
Safety and Efficacy of Intracanalicular Dexamethasone Compared to Loteprednol Etabonate in Patients With Keratoconus
|
Early Phase 1 | |
| Completed |
NCT04186949 -
Early Origins of Allergy and Asthma
|
||
| Completed |
NCT02127801 -
Single Ascending-dose Study of the Efficacy, Safety, Tolerability, and Pharmacokinetics of REGN1908-1909 in Allergic, Adult Participants
|
Phase 1 | |
| Enrolling by invitation |
NCT05011071 -
The Alberta BLOOM Premature Child Study
|
||
| Not yet recruiting |
NCT06330974 -
Allergy, Asthma, and Atopic Eczema in Finland
|
||
| Terminated |
NCT02601690 -
Observational Analysis of T Cell Responses to SPIREs for Multiple Allergens in Subjects With Allergy in North America
|
||
| Completed |
NCT02596321 -
A Study Investigating the Immunologic Effects and Safety of 60-day Treatment of the ALK HDM Tablets in Adult Subjects With HDM-Induced Allergic Rhinitis and/or Atopic Asthma
|
Phase 3 | |
| Completed |
NCT02306473 -
The Leaky Lung Test
|
Early Phase 1 |